Back to today’s briefing

Story perspectives

AMD Invests $20M in AI Drug Discovery Amid Downgrade

1/13/2025

35 6

Summary

Story summary

Advanced Micro Devices (AMD) is making strategic moves in response to shifting AI regulations and fierce competition, particularly from the U.S. and EU. By investing $20 million in AI-driven drug discovery with Absci Corporation, AMD aims to innovate. However, analysts warn investors to consider emerging AI stocks for better returns, as AMD struggles in the AI GPU market, resulting in a recent downgrade.

1 of 1

Story summary

Advanced Micro Devices (AMD) is making strategic moves in response to shifting AI regulations and fierce competition, particularly from the U.S. and EU. By investing $20 million in AI-driven drug discovery with Absci Corporation, AMD aims to innovate. However, analysts warn investors to consider emerging AI stocks for better returns, as AMD struggles in the AI GPU market, resulting in a recent downgrade.